OurBrainBank Wins Forbes EQ BrandVoice 2024: First Article Features Jessica Morris’s book
OBB founder Jessica Morris’s book is excerpted by Forbes.
Read more
UK ranks 22nd out of 29 comparable countries for survival of Brain Cancer
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Experimental GBM treatment — DC Vax — is hoped to be moving forward in the UK
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
White House Cancer Moonshot
OurBrainBank is proud that the White House invited us to be part of the ambitious Cancer Moonshot effort. Read the latest from Washington DC.
OurBrainBank at SNO — Society for Neuro-Oncology — Annual Conference
Executive Director Kelli Duprey presented our poster about treatment disparities at SNO 2023
Clinical trial for people newly diagnosed with glioblastoma
Clinical trial for people newly diagnosed with glioblastoma
Stanford Researchers look to Artificial Intelligence to help plan GBM treatment
Model could help doctors identify patients with cellular characteristics that indicate more aggressive tumors, and flag them for accelerated follow-up.
OurBrainBank benefit event in Connecticut Nov. 22, 2024
A good time was had by all at a festive evening of fun, live music, great food and drinks — all to benefit OurBrainBank. Let us know if you’d like to host a benefit event for us.
OurBrainBank at AONN+ Annual Meeting 2024
OurBrainBank is at the AONN+ (Academy of Oncology Nurse & Patient Navigators) annual conference in Las Vegas. Stop by our booth and poster to meet Executive Director Kelli Duprey and learn about our survey of disparities in GBM treatment across the USA.
MyTumorID — learn about vital tumor testing
Every brain tumor experience is unique, and every patient deserves a better chance at survival, a better chance at an adequate quality of life, and the best information available to make decisions for their treatment.
Demand More! Help us make the Glioblastoma Bill of Rights a reality
Our survey showed serious disparities in GBM care across the USA. Let’s tell the country and make change!
SUBSCRIBE TO OUR NEWSLETTER
GET INVOLVED
